European Organisation For Research And Treatment Of Cancer - Eortc

This study tested whether the drug nintedanib could help people with a rare lung cancer called malignant pleural mesothelioma. Patients who had stable disease or improvement after initial chemotherapy were given either nintedanib or a placebo to see if it delayed cancer growth. T…

This trial tested a personalized treatment approach for post-pubertal patients with a rare brain cancer called medulloblastoma. It aimed to use a targeted drug (sonidegib) and lower radiation doses for patients with a specific genetic subtype (SHH-activated) to improve effectiven…